BrightSpring Health Services, Inc. (NASDAQ:BTSG - Get Free Report) has received a consensus rating of "Moderate Buy" from the fifteen ratings firms that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and fourteen have issued a buy rating on the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $18.50.
A number of equities analysts recently commented on BTSG shares. UBS Group lifted their price objective on BrightSpring Health Services from $16.00 to $20.00 and gave the stock a "buy" rating in a research note on Wednesday, October 30th. KeyCorp began coverage on shares of BrightSpring Health Services in a research report on Friday, October 11th. They set a "sector weight" rating for the company. Wells Fargo & Company raised their price target on shares of BrightSpring Health Services from $17.00 to $21.00 and gave the company an "overweight" rating in a research report on Wednesday, November 27th. CJS Securities started coverage on shares of BrightSpring Health Services in a report on Thursday. They issued an "outperform" rating and a $27.00 price target on the stock. Finally, Bank of America raised their target price on BrightSpring Health Services from $19.00 to $21.00 and gave the stock a "buy" rating in a research report on Wednesday, December 11th.
Read Our Latest Research Report on BTSG
Hedge Funds Weigh In On BrightSpring Health Services
Hedge funds have recently modified their holdings of the company. California State Teachers Retirement System acquired a new stake in BrightSpring Health Services in the 1st quarter valued at approximately $59,000. Bank of New York Mellon Corp boosted its position in shares of BrightSpring Health Services by 16.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 156,911 shares of the company's stock worth $1,783,000 after acquiring an additional 21,760 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank acquired a new position in BrightSpring Health Services in the 2nd quarter valued at approximately $126,000. nVerses Capital LLC bought a new position in BrightSpring Health Services in the 2nd quarter valued at about $55,000. Finally, Rhumbline Advisers grew its position in BrightSpring Health Services by 20.4% during the second quarter. Rhumbline Advisers now owns 73,643 shares of the company's stock valued at $837,000 after buying an additional 12,479 shares during the period.
BrightSpring Health Services Price Performance
Shares of BTSG stock traded up $0.32 during trading hours on Monday, hitting $18.88. 1,166,081 shares of the company's stock were exchanged, compared to its average volume of 1,484,109. The company has a debt-to-equity ratio of 1.63, a current ratio of 1.35 and a quick ratio of 0.97. The stock has a market cap of $3.29 billion and a price-to-earnings ratio of -72.62. BrightSpring Health Services has a 52 week low of $7.85 and a 52 week high of $20.25. The stock's 50-day moving average is $17.57 and its 200-day moving average is $14.14.
BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last issued its quarterly earnings results on Friday, November 1st. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.07). The business had revenue of $2.91 billion for the quarter, compared to the consensus estimate of $2.72 billion. BrightSpring Health Services had a positive return on equity of 4.16% and a negative net margin of 0.38%. The firm's quarterly revenue was up 28.8% on a year-over-year basis. As a group, research analysts forecast that BrightSpring Health Services will post 0.59 EPS for the current year.
About BrightSpring Health Services
(
Get Free ReportBrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Recommended Stories
Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.